Stock Events

Stock Events

Sight Sciences

$8.93

5

+$0.00+0%Wednesday 01:55

Statistics

Day High

8.93

Day Low

8.93

52W High

8.93

52W Low

4.51

Volume

86

Avg. Volume

-

Mkt Cap

491.94M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Earnings

Nov 4Expected

Q3 2025

Q1 2026

Q2 2026

Next

-0.25

-0.2

-0.14

-0.08

Expected EPS

-0.123254

Actual EPS

N/A

Financials

-49.67%Profit Margin

Unprofitable

2020

2021

2022

2023

2024

2025

77.36MRevenue

-38.43MNet Income

Analyst Ratings

$9.33Average Price Target

The highest estimate is ⁦14.00⁩.
From 3 ratings within the last 6 months. This is not an investment recommendation.

Buy

67%

Hold

33%

Sell

0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SGHT.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Align Technology

Align Technology provides medical devices for dental procedures, competing in the broader medical device market similar to Sight Sciences' focus on ophthalmic and optometric devices.

Johnson & Johnson

Johnson & Johnson offers a wide range of medical devices, including those for eye health, directly competing with Sight Sciences' products in the ophthalmology sector.

AbbVie, through its acquisition of Allergan, competes in the eye care market, particularly in treatments for conditions like dry eye, which could overlap with Sight Sciences' patient demographic.

Novartis provides advanced eye care products through its Alcon division, making it a direct competitor in the ophthalmology and optometry markets.

Cooper Companies

The Cooper Companies specialize in contact lens and medical devices for eye care, positioning them as competitors in the vision health market alongside Sight Sciences.

Bausch Health Companies

Bausch Health Companies, through its eye health division, offers products that compete in the same space as Sight Sciences, particularly in surgical and pharmaceutical eye care.

STAAR Surgical specializes in implantable lenses and other products for the eye, competing with Sight Sciences in the area of surgical interventions for vision correction.

Integra Lifesciences

Integra LifeSciences manufactures medical devices, including those for eye surgery, competing with Sight Sciences in the broader market for surgical medical devices.

Penumbra, Inc. offers innovative medical devices across various fields, including a potential overlap in the eye care sector, positioning it as a competitor in the medical device market.

About

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Show More

CEO

ISIN

US82657M1053

Listings

0 Comments

Share your thoughts

FAQs

What is Sight Sciences stock price today?▼

The current price of SGHT.BOATS is $8.93 USD — it has increased by +0% in the past 24 hours. Watch Sight Sciences stock price performance more closely on the chart.

What is Sight Sciences stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Sight Sciences stocks are traded under the ticker SGHT.BOATS.

What is Sight Sciences market cap?▼

Today Sight Sciences has the market capitalization of 491.94M

When is the next Sight Sciences earnings date?▼

Sight Sciences is going to release the next earnings report on November 4, 2026.

What were Sight Sciences earnings last quarter?▼

SGHT.BOATS earnings for the last quarter are -0.08 USD per share, whereas the estimation was -0.17 USD resulting in a +51.81% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Sight Sciences revenue for the last year?▼

Sight Sciences revenue for the last year amounts to 77.36M USD.

What is Sight Sciences net income for the last year?▼

SGHT.BOATS net income for the last year is -38.43M USD.

In which sector is Sight Sciences located?▼

Sight Sciences operates in the Other sector.

When did Sight Sciences complete a stock split?▼

Sight Sciences has not had any recent stock splits.